Skip to content

Focused Extracorporeal Shock Wave Therapy (ESWT) Versus Traditional Physiotherapy in the Treatment of Trigger Finger

Focused Extracorporeal Shock Wave Therapy (ESWT) Versus Traditional Physiotherapy in the Treatment of Trigger Finger: a Randomized Controlled Study

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04855942
Enrollment
0
Registered
2021-04-22
Start date
2021-05-01
Completion date
2022-08-31
Last updated
2022-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stenosing Tenosynovitis, Trigger Finger

Keywords

extracorporeal shock wave, trigger finger, stenosing tenosynovitis

Brief summary

Trigger finger is the common name of stenosing tenosynovitis of fingers, caused by repetitive trauma. Conservative treatment includes NSAIDs or other analgesic agents, activity modification, splint, and physiotherapy. Operation could be considered if conservative treatments fails. With literature reviewed, there is no treatment which is both non-invasive and effective, and also could avoid recurrence well. Extracorporeal shock wave therapy could induce angiogenesis, anti-inflammatory reaction, and recruitment of fibroblast. Although extracorporeal shock wave has been utilized in musculoskeletal diseases for more than twenty years, there is no well-designed clinical trial to prove the effectiveness of extracorporeal shock wave in treating trigger finger. The purpose of this study is to compare the effectiveness of extracorporeal shock wave therapy with traditional physical therapy for the management of trigger finger.

Interventions

2000 impulses of 5 Hz and 0.32 mJ/mm2 , twice per week for 3 weeks

DEVICEphysiotherapy

therapeutic ultrasound, 12 times in 3 weeks

Sponsors

Cheng-Hsin General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Intervention model description

Our study design is mainly to compare the therapeutic effect to trigger finger between extracorporeal shock wave (PiezoWave2 ECO, produced by Richard Wolf) and traditional physiotherapy.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Quinnel classification grade 2 or 3 * who has only one trigger

Exclusion criteria

* who had ever treated the trigger finger * who has other musculoskeletal disease of the upper limb * who has severe coagulopathy disease * who is pregnant * who has arrhythmia or has a pacemaker * there is sensory impairment, scar, edema at the trigger finger * who has cognitive dysfunction

Design outcomes

Primary

MeasureTime frameDescription
Quinnell stages of triggering15 weeksQuinnell stages of triggering classifies the trigger finger using five types during flexion and extension: normal movement (Type 0), uneven movement (Type I), actively correctable (Type II), passively correctable (Type III) and fixed deformity (Type IV).
11-point numeric scale of pain15 weeksThe 11-point numeric scale of pain requires the patient to rate their pain on a defined scale. 0 is no pain and 10 is the worst pain imaginable.
Chinese quick DASH (disabilities of the Arm, Shoulder, and Hand questionnaire)15 weeksThis questionnaire is a self-administered region-specific outcome instrument developed as a measure of self-rated upper-extremity disability and symptoms. The investigators chose the first two components: the disability and symptom section (11 items, scored 1-5). The lower score means better condition of upper limbs, and vice versa.
strength of hand grip15 weeksThe strength of hand grip is to measure the maximum isometric strength of the hand and forearm muscles by a electicial grip strength device.
sonographic image15 weeksThe investigators would record the characteristics of acquired sonographic images, such like the thickness of finger flexor tendon and A1 pulley, the presence of tendon sheath effusion, and the presence of increased vascularity by Doppler images.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026